Cladribine — an old newcomer for pulsed immune reconstitution in MS

    loading  Checking for direct PDF access through Ovid

Abstract

The EMA has approved cladribine tablets for the treatment of multiple sclerosis. The drug is not new, and the journey to its approval has been a long one, but the old concepts that cladribine therapy are based on provide a new option for the possibility of drug-free remission.

Related Topics

    loading  Loading Related Articles